ONIVYDE (IRINOTECAN LIPOSOME) 43 MG/10 ML INJECTION

A form of the anticancer drug irinotecan hydrochloride that is contained in very tiny, fat-like particles. Onivyde is used together with fluorouracil and leucovorin to treat a certain type of pancreatic cancer that has spread to other parts of the body and has gotten worse after treatment with gemcitabine anticancer therapy.

Onivyde may have fewer side effects and work better than irinotecan hydrochloride.

Onivyde (Irinotecan Liposome) Injection suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Onivyde (Irinotecan Liposome) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Onivyde (Irinotecan Liposome) is manufactured by Merrimack Pharmaceuticals, Inc.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Onivyde (Irinotecan Liposome) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

ONIVYDE is topoisomerase inhibitor indicated in combination with fluorouracil and leucovorin, for treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression to the gemcitabine-based therapy.

Limitation of Use:

Limitations of use ONIVYDE is not indicated as a single agent for treatment of patients with metastatic adenocarcinoma of the pancreas. It is also not to be substituted with other drugs containing Irinotecan HCL.

Medicine Name: Onivyde
Generic Name: Irinotecan Liposome
Approval Date: Oct 22, 2015
Available as (Form & Strength): Injection: 43mg/10ml
Company Name: Merrimack Pharmaceuticals, Inc.